home / stock / bmndf / bmndf quote
Last: | $0.372 |
---|---|
Change Percent: | 0.0% |
Open: | $0.372 |
Close: | $0.372 |
High: | $0.372 |
Low: | $0.372 |
Volume: | 400 |
Last Trade Date Time: | 07/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.372 | $0.372 | $0.372 | $0.372 | $0.372 | 400 | 07-18-2024 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 2,900 | 07-17-2024 |
$0.25 | $0.25 | $0.25 | $0.25 | $0.25 | 529 | 07-11-2024 |
$0.3396 | $0.33 | $0.3396 | $0.3396 | $0.33 | 630 | 07-09-2024 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 500 | 07-08-2024 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 100 | 07-05-2024 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 1,000 | 07-02-2024 |
$0.1633 | $0.15 | $0.1633 | $0.1633 | $0.15 | 3,000 | 06-25-2024 |
$0.1141 | $0.1141 | $0.1141 | $0.1141 | $0.1141 | 1,485 | 06-20-2024 |
$0.089 | $0.089 | $0.089 | $0.089 | $0.089 | 550 | 06-13-2024 |
$0.11 | $0 | $0.11 | $0 | $0 | 13 | 05-14-2024 |
$0.11 | $0 | $0.11 | $0 | $0 | 20 | 04-17-2024 |
$0.11 | $0 | $0.11 | $0 | $0 | 19 | 04-12-2024 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 262 | 04-04-2024 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 115 | 03-25-2024 |
$0.34 | $0.35 | $0.34 | $0.35 | $0.34 | 663 | 03-22-2024 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 2,500 | 03-20-2024 |
$0.2466 | $0.2466 | $0.2466 | $0.2466 | $0.2466 | 1,000 | 03-19-2024 |
$0.3 | $0.2466 | $0.3 | $0.3 | $0.2466 | 7,497 | 03-18-2024 |
$0.36 | $0.36 | $0.36 | $0.36 | $0.36 | 147 | 03-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / July 18, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI) , a leading biotech company dedicated to developing the next-generation of pharmaceuticals targeting the root causes of neurological disorders, announced the ...
Biomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by ta...